Sickle Cell Disease and Cardiovascular Risk- Red Cell Exchange SCD-CARRE

$2,667,908UH3FY2022HLNIH

University Of Maryland Baltimore, Baltimore MD

Investigators

Mark Thomas Gladwincontact

Linked publications, trials & patents

Paper 39478346 Paper 38746469 Paper 38559268 Paper 38400625 Paper 37439373 Paper 36763969 Paper 35549664 Paper 35384045 Paper 34516300

View original record on NIH RePORTER →